Latest Updates

April 11, 2026

FDA PDUFA Dates 2026: The Complete Biotech Catalyst Calendar Guide

What a PDUFA Date Actually Is The Prescription Drug User Fee Act requires the FDA to review New Drug Applications (NDAs) and Biologics License Applications (BLAs) within a set timeframe — typically 10 months for standard review, 6 months for priority review. The PDUFA date is the FDA’s self-imposed deadline to complete that review. It […]

Read More →

March 21, 2026

Why Biotech Stocks Dilute More Than Any Other Sector

If you’ve ever watched a promising biotech stock cut in half despite no bad news, only to find a prospectus supplement filed the next morning, you’ve experienced the most common phenomenon in biotech investing. Dilution isn’t a bug in the biotech model — it’s a structural feature that any investor in the sector needs to […]

Read More →